SEC Form 4 · accession 0000899243-18-010652
ALPINE IMMUNE SCIENCES, INC. · ALPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Peetz
Director
Period of report
Apr 20, 2018
Accepted (ET)
Apr 24, 2018 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626199
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.91 | Apr 20, 2018 | A | 7,650 | A | — | Apr 19, 2028 | Common Stock | 7,650 | 7,650 | D |
Explanation of responses
- F1The shares shall vest in 36 equal monthly installments commencing on May 20, 2018.